Bessemer Group
CORT icon

Bessemer Group’s Corcept Therapeutics CORT Stock Holding History

Bessemer Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.65M Sell
76,446
-171
-0.2% -$10.3K 0.01% 496
2026
Q1 		$3.09M Buy
76,617
+96
+0.1% +$3.59K ﹤0.01% 685
2025
Q4 		$2.66M Buy
76,521
+75,892
+12,066% +$5.96M ﹤0.01% 771
2025
Q3 		$53K Buy
629
+342
+119% +$24.7K ﹤0.01% 1423
2025
Q2 		$21K Buy
287
+70
+32% +$5.08K ﹤0.01% 1560
2025
Q1 		$25K Sell
217
-57
-21% -$3.47K ﹤0.01% 1458
2024
Q4 		$14K Buy
274
+123
+81% +$6.45K ﹤0.01% 1622
2024
Q3 		$7K Sell
151
-79
-34% -$2.81K ﹤0.01% 1778
2024
Q2 		$7K Hold
230
– – ﹤0.01% 1608
2024
Q1 		$6K Sell
230
-24
-9% -$567 ﹤0.01% 1663
2023
Q4 		$9K Hold
254
– – ﹤0.01% 1610
2023
Q3 		$7K Sell
254
-387
-60% -$11.2K ﹤0.01% 1652
2023
Q2 		$14K Buy
+641
New +$14.8K ﹤0.01% 1583
2022
Q1 		– Sell
-195
Closed -$4K – 1841
2021
Q4 		$4K Buy
+195
New +$3.96K ﹤0.01% 1624
2019
Q2 		– Sell
-132
Closed -$2K – 1663
2019
Q1 		$2K Sell
132
-687
-84% -$8.54K ﹤0.01% 1668
2018
Q4 		$11K Hold
819
– – ﹤0.01% 1631
2018
Q3 		$11K Buy
+819
New +$11.4K ﹤0.01% 1588

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bessemer Group's CORT Position: Q2 2026 in Review

Bessemer Group reduced its Corcept Therapeutics (CORT) stake by 0.22% in Q2 2026, selling an estimated $10.3K and leaving 76,446 shares worth $6.65M. The position accounts for 0.01% of the portfolio, ranked #496.

Bessemer Group first reported a position in CORT in Q3 2018 and has held it in 17 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Bessemer Group held 76,446 shares of Corcept Therapeutics worth $6.65M as of Q2 2026.
  • Bessemer Group sold 171 Corcept Therapeutics shares in Q2 2026, an estimated $10.3K.
  • Corcept Therapeutics made up 0.01% of Bessemer Group's portfolio in Q2 2026, its #496 holding.
  • Bessemer Group first reported a position in Corcept Therapeutics in Q3 2018 and has held it in 17 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.